000 | 01418 a2200385 4500 | ||
---|---|---|---|
005 | 20250513083039.0 | ||
264 | 0 | _c19960122 | |
008 | 199601s 0 0 spa d | ||
022 | _a0213-005X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLópez-Brea, M | |
245 | 0 | 0 |
_a[Treatment of peptic ulcer and gastritis associated with Helicobacter pylori]. _h[electronic resource] |
260 |
_bEnfermedades infecciosas y microbiologia clinica _c |
||
300 |
_a422-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xtherapeutic use |
650 | 0 | 4 |
_aBismuth _xtherapeutic use |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
650 | 0 | 4 |
_aDuodenitis _xdrug therapy |
650 | 0 | 4 |
_aGastritis _xcomplications |
650 | 0 | 4 |
_aHelicobacter Infections _xcomplications |
650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoma, B-Cell, Marginal Zone _xetiology |
650 | 0 | 4 |
_aMetronidazole _xtherapeutic use |
650 | 0 | 4 |
_aOrganometallic Compounds _xtherapeutic use |
650 | 0 | 4 |
_aPeptic Ulcer _xdrug therapy |
650 | 0 | 4 |
_aSalicylates _xtherapeutic use |
650 | 0 | 4 |
_aStomach Neoplasms _xetiology |
700 | 1 | _aAlarcón, T | |
773 | 0 |
_tEnfermedades infecciosas y microbiologia clinica _gvol. 13 _gno. 7 _gp. 422-8 |
|
999 |
_c8519073 _d8519073 |